According to an article published by Foxnews entitled ” FDA approves new oral MS drug, Tecfidera” the following information reveals just how big the market is for NRF2 activating medications and supplements. Tecfidera has been FDA approved to treat just one disease, Multiple Sclerosis. From studies published on Pubmed.gov, NRF2 deficiencies is potentially tied to… Continue reading What Tecfidera Tells Us About the Size of the Nrf2 Medical and Supplementation Market
Tag: multiple sclerosis
Tecfidera (BG-12) Nrf2 Activator Approved by FDA for Multiple Sclerosis (MS) Treatment
Although there is no treatment that will cure Multiple Sclerosis, there are three oral medications approved by the FDA to be a first-line treatment to slow down the progression of the disease. Dimethyl Fumarate (Tecfidera, Biogen Idec) joins fingolimod (Gilenya) and teriflunomide (Aubagio) as the new “kid on the block”. It is specifically approved for… Continue reading Tecfidera (BG-12) Nrf2 Activator Approved by FDA for Multiple Sclerosis (MS) Treatment
Nrf2 Drug Submitted for FDA approval for Multiple Sclerosis (MS)
UPDATE April 2013 Biogen’s BG-12 has been approved by the FDA and is now marketed under the name Tecfidera. Google News reported 28 Feb 2012 that Biogen Idec has submitted for FDA approval for new drug to treat Multiple Sclerosis. The drug is known as BG-12 (Dimethyl Fuerate). Multiple Sclerosis impacts more that 400, 000… Continue reading Nrf2 Drug Submitted for FDA approval for Multiple Sclerosis (MS)